Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

HealthInvest Partners AB’s Top Pick and Favorite Non-Healthcare Stocks

#3. Triple-S Management Corp. (NYSE:GTS)

 – Shares Owned by HealthInvest Partners AB (as of June 30): 532,876

 – Value of HealthInvest Partners AB’s Holding (as of June 30): $13.02 Million

The fund management company co-founded by Carl Bennet and Anders Hallberg increased its holding in Triple-S Management Corp. (NYSE:GTS) by 5% during the April-to-June period, ending the second quarter with 532,876 shares. The upped position was worth $13.02 million and constituted 6.0% of the value of the firm’s U.S. equity portfolio. Triple-S Management, one of the most significant players in the managed care industry in Puerto Rico, has seen its shares gain 7% thus far in 2016. The company also participates in the life insurance market and property insurance market. Triple-S Management’s net consolidated premiums earned for the first quarter of 2016 grew by 38.7% year-over-year to $738.5 million, reflecting the change in the Medicaid delivery model from an Administrative Services Only (ASO) model to a risk-based one. Richard S. Pzena’s Pzena Investment Management had 1.42 million shares of Triple-S Management Corp. (NYSE:GTS) among its holdings on March 31.

Follow Triple-S Management Corp (NYSE:GTS)
Trade (NYSE:GTS) Now!

#2. GNC Holdings Inc. (NYSE:GNC)

 – Shares Owned by HealthInvest Partners AB (as of June 30): 681,955

 – Value of HealthInvest Partners AB’s Holding (as of June 30): $16.57 Million

HealthInvest Partners AB had 681,955 shares of GNC Holdings Inc. (NYSE:GNC) in its portfolio at the end of June, 95,000 shares more than it did at the end of March. The increased position was valued at $16.57 million on June 30. The health and nutrition products retailer has had 34% of its market value erased since the beginning of 2016, as the company suspended its guidance for the year and its CEO stepped down after a failed turnaround attempt. The fresh resignation of CEO Michael G. Archbold and the appointment of Director Robert F. Moran as interim CEO suggests that the nutritional-supplement specialist is struggling to turn its business around. GNC Holdings saw its second quarter same-store sales decrease by 3.7% year-over-year in domestic company-owned stores. The company sells products through a worldwide network of more than 9,000 locations, but the fast-increasing power of e-commerce seems to have put massive pressure on GNC’s performance. Glenn Russell Dubin’s Highbridge Capital Management owned roughly 738,000 shares of GNC Holdings Inc. (NYSE:GNC) at the end of the first quarter.

Follow Gnc Holdings Inc. (NYSE:GNC)
Trade (NYSE:GNC) Now!

Top Stock Pick: Anika Therapeutics Inc. (NASDAQ:ANIK)

 – Shares Owned by HealthInvest Partners AB (as of June 30): 412,588

 – Value of HealthInvest Partners AB’s Holding (as of June 30): $22.14 Million

Anika Therapeutics Inc. (NASDAQ:ANIK) was the largest equity holding in the Swedish investment firm’s pool of holdings at the end of the June quarter, accounting for 10.2% of the value of the firm’s equity portfolio. HealthInvest Partners AB trimmed its Anika stake by 15% during the second quarter to 412,588 shares, which was valued at $22.14 million on June 30. The shares of the integrated orthopedic medicines company are 28% in the green year-to-date. The company’s orthopedic medicine portfolio comprises Orthovisc and Monivisc, two products designed to alleviate pain and restore joint function by replenishing depleted hyaluronic acid. In early June, Anika Therapeutics announced the commercial launch of Cingal, the company’s third-generation viscosupplement, in the European Union. Cingal was already available in Canada and the company continues to pursue regulatory approval of the product in the United States as well. The company’s second quarter revenue jumped by 16% year-over-year to $26.6 million, after registering a year-over-year growth rate of 44% in the first quarter. Ken Fisher’s Fisher Asset Management has 57,719 shares of Anika Therapeutics Inc. (NASDAQ:ANIK) in its portfolio as of June 30.

Follow Anika Therapeutics Inc. (NASDAQ:ANIK)
Trade (NASDAQ:ANIK) Now!

Disclosure: None

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.